Manuel Cano, MD, PhD

Original Contribution

Drug-Eluting Stents in the Elderly: Long-Term (> One Year) Clinical Outcomes of Octogenarians in the DESIRE (Drug- Eluting Stent

09/10/2008

Amanda G.R.M. Sousa , MD, PhD;

Jose de Ribamar Costa Jr., MD, PhD;

Ricardo A. Costa , MD, PhD;

Galo Maldonado , MD;

J. Eduardo Sousa , MD, PhD;

Enilton T. Egito , MD;

Edson R. Romano , MD;

Marcos Barbosa , MD;

Ricardo Pavanello , MD;

César Jardim , MD;

Abrão Cury , MD;

Otávio Berwanger , MD, PhD;

Manuel Cano , MD, PhD;

Adriana Costa Moreira , MD, PhD;

ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...

ABSTRACT: Background. Despite...

09/10/2008

Journal of Invasive Cardiology

Original Contribution

Impact of PCI Appropriateness in the Long-Term Outcomes of Consecutive Patients Treated With Second-Generation Drug-Eluting Stents

06/15/2017

Adriana Costa Moreira , MD, PhD;

Amanda G.R.M. Sousa , MD, PhD;

Jose de Ribamar Costa Jr., MD, PhD;

Ricardo A. Costa , MD, PhD;

Lucas Damiani , MS;

Cantidio Campos Neto , BS , PhD;

Galo Maldonado , MD;

J. Eduardo Sousa , MD, PhD;

Ana Cristina Seixas , MD, PhD;

Manuel Cano , MD, PhD;

We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...

We sought to assess the outcomes...

06/15/2017

Journal of Invasive Cardiology